United Therapeutics Corp (NASDAQ:UTHR)

Delayed Data
As of Dec 02
 +2.76 / +1.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 295.00, with a high estimate of 375.00 and a low estimate of 150.00. The median estimate represents a +5.97% increase from the last price of 278.37.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 22

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -6.36%
Growthannually 13.56%


Growthquarterly 0.11%
Growthannually 16.25%
Key to the earnings and sales forecast charts.